The digital health market is welcoming new IPOs for the first time in years. Bankers and investors think these 9 startups ...

It's an apt description. Omada has made its name with sophisticated analytics, IoT gadgetry (including a digital scale) and mobile solutions designed to prevent the onset of Type 2 diabetes and ...

Omada Health (OMDA) is a strong buy. Backed by 29 studies, key partnerships with Cigna and CVS drive growth, credibility, and ...

Omada builds programs that employees don’t just try, but stick with – resulting in reduced healthcare costs that deliver long term changes in health behavior and increased ROI.

Omada’s move toward a public exit comes as the number of IPOs in digital health have withered in recent years. In 2021, nearly two dozen firms notched a public exit as the sector saw record ...

“Omada meets the highest clinical standards in our care delivery, and we’re honored to be the first digital health program to gain NCQA accreditation for Type 2 diabetes programming,” says ...

While Omada has long performed screenings of users for conditions like anxiety and depression, follow-up treatment was hampered by issues referring care out to behavioral health specialists.

Omada Health, a San Francisco startup that makes digital health therapy programs for people with type 2 diabetes and other serious but potentially treatable issues, has raised $23 million in new ...

Back in December 2011, Omada Health grabbed $800K in seed funding from a long list of notable investors, including NEA, Aberdare, Kapor Capital, TriplePoint Ventures and Esther Dyson. After a year ...